UPS brings cryogenic tracking to Europe
March 15, 2016
UPS is providing healthcare customers in Europe with access to end-to-end product protection and capability to ship parcels in a cryogenic environment.
The UPS Temperature True Cryo service includes real-time tracking and intervention, which, when combined with UPS’s risk mitigation products and global network of control towers, will provide complete visibility for shipments at every stage of the supply chain journey.
The service uses Cryoport's cryogenic containers, which allow UPS customers to use liquid nitrogen stored in dry vapour form to keep products frozen at -150ËšC for ten days while in transit or storage. When meeting minimum volume levels, shipments can also be paired with UPS Proactive Response Secure, a financial protection service that provides coverage for these time- and temperature-sensitive shipments.
"When products requiring cryopreservation are on the move, customers want peace of mind that their shipments are safeguarded, so bringing this to the Europe market was a logical next step as we continue to expand our best-in-class logistics services globally for the healthcare and life science industries,” said Jan Denecker, director of healthcare marketing for UPS Europe. “UPS Temperature True Cryo combines innovative packaging, 24/7 monitoring and intervention capabilities for the most critical time- and temperature-sensitive specimens across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health.”
In a recent global study, UPS found that the top pain points in healthcare supply chain management were product security, damage and spoilage. The Temperature True Cryo service along with UPS Proactive Response Secure should help researchers, lab technicians and healthcare practitioners shipping often-invaluable specimens and samples requiring cryopreservation.
The service provides storage, transportation and packaging for products ranging from cryogenic to ambient, specifically tailored for companies in the pharmaceutical, biotech and medical device industries. These services are complemented by regulatory expertise and a global network of 51 UPS healthcare-dedicated facilities.